Cargando…
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
Pancreatic ductal adenocarcinoma has a median survival of less than 6 months from diagnosis. This is due to the difficulty in early diagnosis, the aggressive biological behaviour of the tumour and a lack of effective therapies for advanced disease. Mammalian heparanase is a heparan-sulphate proteogl...
Autores principales: | Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375333/ https://www.ncbi.nlm.nih.gov/pubmed/11953884 http://dx.doi.org/10.1038/sj.bjc.6600232 |
Ejemplares similares
-
Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma
por: Rohloff, J, et al.
Publicado: (2002) -
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002) -
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004) -
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
por: Sarela, A I, et al.
Publicado: (2002) -
High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
por: Hiyama, E, et al.
Publicado: (2004)